PLXS News and Press, Plexus Corp. From 01/22/20

Record quarterly revenue of $852 million during the fiscal first quarter of 2020 GAAP diluted EPS of $1.03 Non-GAAP adjusted diluted EPS of $1.00, excluding a net benefit of $0.03 per share related to special tax items Initiates fiscal second quarter 2020 revenue guidance of $790 ...

NEENAH, Wisc., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS) announced today it will release its fiscal first quarter 2020 results after the market closes on Wednesday, January 22, 2020.  Plexus’ management will host a conference call to discuss its first quarter resul...

Image source: The Motley Fool. Plexus   (NASDAQ: PLXS) Q4 2019 Earnings Call Oct 24, 2019 , 8:30 a.m. ET Operator Continue reading

Plexus Corp. (PLXS) Q4 2019 Earnings Conference Call October 24, 2019 8:30 AM ET Company Participants Heather Beresford - Senior Director of Communications & Investor Relations Todd Kelsey - President & Chief Executive Officer Steve Frisch - Executive Vice President &...

The following slide deck was published by Plexus Corp. in conjunction with their 2019 Q4 earnings Read more ...

Plexus (NASDAQ: PLXS ): Q4 Non-GAAP EPS of $0.93 beats by $0.07 ; GAAP EPS of $1.23 beats by $0.41 . Revenue of $810.2M (+5.1% Y/Y) beats by $34.18M . Press Release More news on: Plexus Corp., Earnings news and commentary, Tech stocks news,

Record fiscal fourth quarter revenue of $810 million and record fiscal 2019 revenue of $3.2 billion Fiscal fourth quarter GAAP diluted EPS of $1.23, including $0.19 of stock-based compensation expense Non-GAAP adjusted diluted EPS of $0.93, excluding a non-cash benefit of $0.35 per share...

NEENAH, Wis., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS) announced today it will release its fiscal fourth quarter 2019 results after the market closes on Wednesday, October 23, 2019.  Plexus’ management will host a conference call to discuss its fourth quarter res...

NEENAH, Wis., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS) announced today that its Board of Directors has approved a new share repurchase program under which the Company is authorized to repurchase up to $50 million of its common stock beginning upon expiration of the Company&#x...

NEENAH, Wis., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS) announced today that its Azteca Manufacturing facility, located in Guadalajara, Mexico, achieved Federal Drug Administration (FDA) approval to manufacture finished, Class III medical devices. This marks Plexus’ ...